NEURODEGENERATION References

1.            Ancelin ML, Christen Y, and Ritchie K. Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dement Geriatr Cogn Disord 24: 1-19, 2007.

2.            Farfara D, Lifshitz V, and Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J Cell Mol Med 12: 762-780, 2008.

3.            Happe S. Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Drugs 63: 2725-2737, 2003.

4.            Moulik PK, and Hardy KJ. Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes. Diabet Med 20: 290-293, 2003.

5.            Nunomura A, Moreira PI, Takeda A, Smith MA, and Perry G. Oxidative RNA damage and neurodegeneration. Curr Med Chem 14: 2968-2975, 2007.

6.         Toth C, Martinez J, and Zochodne DW. RAGE, diabetes, and the nervous system. Curr Mol Med 7: 766-776, 2007.

7.            Whitmer RA. Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 7: 373-380, 2007.